SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 147 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $255,000 | -69.8% | 594,108 | +129.7% | 0.00% | -71.4% |
Q1 2021 | $843,000 | -68.6% | 258,662 | -67.1% | 0.01% | -70.8% |
Q4 2020 | $2,681,000 | -40.2% | 786,255 | -28.5% | 0.02% | -48.9% |
Q3 2020 | $4,487,000 | +54.7% | 1,099,695 | +28.1% | 0.05% | +51.6% |
Q2 2020 | $2,901,000 | +385.9% | 858,247 | +235.1% | 0.03% | +287.5% |
Q1 2020 | $597,000 | -45.7% | 256,085 | -15.2% | 0.01% | -27.3% |
Q4 2019 | $1,099,000 | +25.5% | 301,874 | +156.6% | 0.01% | -42.1% |
Q2 2017 | $876,000 | -36.8% | 117,647 | -44.8% | 0.02% | -32.1% |
Q1 2017 | $1,386,000 | +607.1% | 213,247 | +381.4% | 0.03% | +600.0% |
Q4 2016 | $196,000 | -87.5% | 44,300 | -81.4% | 0.00% | -87.5% |
Q2 2016 | $1,563,000 | +376.5% | 237,901 | +361.6% | 0.03% | +357.1% |
Q1 2016 | $328,000 | +245.3% | 51,540 | +226.2% | 0.01% | +250.0% |
Q4 2015 | $95,000 | +37.7% | 15,800 | +36.2% | 0.00% | +100.0% |
Q3 2015 | $69,000 | -59.2% | 11,600 | -48.7% | 0.00% | -66.7% |
Q2 2013 | $169,000 | – | 22,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,383,466 | $139,917,000 | 12.64% |
ASHFORD CAPITAL MANAGEMENT INC | 362,615 | $6,872,000 | 1.07% |
NEXTHERA CAPITAL LP | 259,300 | $4,914,000 | 0.91% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 639,856 | $12,125,000 | 0.89% |
Sonora Investment Management, LLC | 249,502 | $4,728,063,000 | 0.76% |
Kazazian Asset Management, LLC | 32,526 | $616,000 | 0.63% |
Piermont Capital Management Inc. | 88,372 | $1,675,000 | 0.55% |
J. Goldman & Co LP | 266,479 | $5,050,000 | 0.26% |
J. Goldman & Co LP | 251,500 | $4,766,000 | 0.25% |
Opaleye Management Inc. | 31,000 | $587,000 | 0.19% |